ethylenimine quinone has been researched along with Osteosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cadenas, E; Qiu, XB; Schönthal, AH | 1 |
| Cadenas, E; Hohenstein, A; Mueller, S; Park, JM; Qiu, X; Schönthal, AH; Wu, RC | 1 |
2 other study(ies) available for ethylenimine quinone and Osteosarcoma
| Article | Year |
|---|---|
Anticancer quinones induce pRb-preventable G2/M cell cycle arrest and apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Aziridines; Benzoquinones; Cell Cycle; Drug Screening Assays, Antitumor; G2 Phase; Humans; Hydrogen Peroxide; Mitosis; Osteosarcoma; Retinoblastoma Protein; Tumor Cells, Cultured | 1998 |
Role of p53 in aziridinylbenzoquinone-induced p21waf1 expression.
Topics: Animals; Antineoplastic Agents; Aziridines; Base Sequence; Benzoquinones; Binding Sites; Breast Neoplasms; Cell Line; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Enzyme Inhibitors; Female; Gene Expression Regulation; HL-60 Cells; Humans; Luciferases; Mice; Osteosarcoma; Promoter Regions, Genetic; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |